| Previous Close | 32.95 |
| Open | 32.91 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 32.65 - 32.97 |
| 52 Week Range | 29.83 - 35.38 |
| Volume | 15,490,145 |
| Avg. Volume | 18,618,693 |
| Market Cap | 194.97B |
| Beta | 1.05 |
| PE Ratio (TTM) | 27.50 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.88%) |
| Ex-Dividend Date | 2017-08-02 |
| 1y Target Est | N/A |
- Barrons.com•yesterday
[$$] Healthy Dividends
When it comes to health care, pharmaceutical companies get a lot of attention, because many offer attractive yields. Pfizer’s (PFE), for example, was 3.9% late last week, and Bristol Myers Squibb’s (BMY) was 2.7%.
- Fortune•2 days ago
The FDA Just Approved a New Pfizer Cancer Drug for a Rare, Vicious Leukemia
The therapy, Besponsa, treats a rapidly progressing version of the disease.
- Zacks•2 days ago
Pfizer's (PFE) Besponsa Gets FDA Nod with a Boxed Warning
Pfizer, Inc.'s (PFE) leukemia candidate, Besponsa received FDA approval, though with a boxed warning on the label.
